| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -9.7e-05 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.00015 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 1.3e-05 | 1 |